
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
BlackRock Future Health ETF (BMED)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: BMED (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 16.55% | Avg. Invested days 57 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 0.82 | 52 Weeks Range 20.57 - 27.02 | Updated Date 06/29/2025 |
52 Weeks Range 20.57 - 27.02 | Updated Date 06/29/2025 |
Upturn AI SWOT
BlackRock Future Health ETF
ETF Overview
Overview
The BlackRock Future Health ETF (NYSEARCA: BDOC) seeks to track the investment results of an index composed of companies that could benefit from innovation and technological improvements in the health care sector. It focuses on companies involved in areas such as precision medicine, robotic surgery, and artificial intelligence in healthcare.
Reputation and Reliability
BlackRock is one of the world's largest asset managers, known for its broad range of investment products and established reputation.
Management Expertise
BlackRock has extensive experience in managing ETFs, with a dedicated team of portfolio managers and analysts.
Investment Objective
Goal
To track the investment results of an index composed of companies that could benefit from innovation and technological improvements in the health care sector.
Investment Approach and Strategy
Strategy: The ETF employs a passive management investment strategy, aiming to replicate the performance of the ICE FactSet Global Future Healthcare Index.
Composition The ETF primarily holds stocks of companies across different market capitalizations involved in the future healthcare industry.
Market Position
Market Share: BDOC's market share is relatively small compared to broader healthcare ETFs.
Total Net Assets (AUM): 51635135
Competitors
Key Competitors
- ARK Genomic Revolution ETF (ARKG)
- Global X Genomics & Biotechnology ETF (GNOM)
- iShares Genomics Immunology and Healthcare ETF (IDNA)
Competitive Landscape
The ETF industry in future health is competitive, with several established players. BDOC competes with more popular and larger ETFs, such as ARKG, which have a longer track record and higher brand recognition. BDOC may offer a slightly different approach to future health, but it needs to distinguish itself to gain a larger market share. BDOCs advantages is the vast infrastructure of the BlackRock ecosystem.
Financial Performance
Historical Performance: Historical performance data needs to be retrieved from financial data providers.
Benchmark Comparison: Benchmark comparison requires specific performance data against the ICE FactSet Global Future Healthcare Index.
Expense Ratio: 0.3
Liquidity
Average Trading Volume
The ETF's average trading volume provides insights into its liquidity and ease of buying or selling shares; BDOC's Average Trading Volume is approxiamately 9,587 shares per day.
Bid-Ask Spread
The bid-ask spread, typically a few cents, reflects the cost of trading the ETF.
Market Dynamics
Market Environment Factors
Economic growth, healthcare regulations, technological advancements, and demographic shifts influence the ETF's performance.
Growth Trajectory
Growth trends depend on the adoption of new healthcare technologies and the performance of companies within the index; strategies will likely remain consistent with a passive strategy.
Moat and Competitive Advantages
Competitive Edge
BDOC's competitive advantage lies in BlackRock's brand, distribution network, and low expense ratio compared to some competitors. The ETFu2019s focused approach on future healthcare innovations may attract investors seeking targeted exposure. However, it needs to differentiate itself more clearly from other healthcare and genomics ETFs. BlackRock's scale and resources also offer a potential advantage in marketing and product development.
Risk Analysis
Volatility
Volatility depends on the specific holdings and overall market conditions.
Market Risk
The ETF is exposed to market risk, sector-specific risk (healthcare), and risks associated with smaller, growth-oriented companies.
Investor Profile
Ideal Investor Profile
The ideal investor is one with a high risk tolerance that is interested in disruptive technologies and future trends in the health care sector.
Market Risk
This ETF is best suited for long-term investors seeking thematic exposure to healthcare innovation.
Summary
BlackRock Future Health ETF (BDOC) offers exposure to innovative companies in the healthcare sector, leveraging BlackRock's expertise. It competes with other thematic ETFs but has a relatively small market share. The ETF is suitable for long-term investors interested in disruptive technologies. Its passive management strategy aims to replicate the index, while BlackRock's brand and distribution network contribute to its competitive edge. Investors should consider the ETF's liquidity, expense ratio, and potential risks before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- BlackRock official website
- ETF.com
- Yahoo Finance
- etfdb.com
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be made after consulting with a qualified financial advisor. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BlackRock Future Health ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

